head-and-neck-cancer

Documents about head-and-neck-cancer

• Metadherin: A pivotal oncogene and therapeutic target in head and neck cancer - a systematic review#307889Europe PMC
• Effect of Nutritional Management on RIOM in Patients With Advanced Head and Neck Cancer#831433ClinicalTrials.gov
• HFHS-1801-A Pilot Study of Immunotherapy As Consolidation Therapy for Patients with Recurrent Head and Neck Cancer#279527ClinicalTrials.gov
• Phase II Study of RAD001 Head and Neck Cancer#800399ClinicalTrials.gov
• Efficacy of Smoking Cessation Intervention for Head and Neck Cancer Patients#907335ClinicalTrials.gov
• Assessment of Different Therapeutic Strategies in Patients With Head and Neck Neoplasms Treated With Radiotherapy#1030705ClinicalTrials.gov
• APG-157 in Locally Advanced Head and Neck Squamous Cell Carcinoma#865781ClinicalTrials.gov
• Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia#994926ClinicalTrials.gov
• ADXS 11-001 Vaccination Prior to Robotic Surgery, HPV-Positive Oropharyngeal Cancer#123457ClinicalTrials.gov
• Boron Neutron Capture Therapy (BNCT) for Locally Recurrent Head and Neck Cancer#844107ClinicalTrials.gov
• Group-Mediated Cognitive Behavioral Resistance Exercise Intervention in Head and Neck Cancer Patients Undergoing Chemoradiation Treatment#891518ClinicalTrials.gov
• Chemoradiotherapy With Elective Low Dose Nodal Radiation for Locally Advanced Head and Neck Cancer#900982ClinicalTrials.gov
• Tumor Metabolism of Head and Neck Cancer in Patients Who Underwent Radiation Therapy Measured With F-18-FDG-PET#967005ClinicalTrials.gov
• Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer#1047970ClinicalTrials.gov
• Validation of 18F-MISO-PET and 18F-FLT-PET#1047655ClinicalTrials.gov
• Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery#230429ClinicalTrials.gov
• Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck#859919ClinicalTrials.gov
• An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)#837230ClinicalTrials.gov
• Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer#805001ClinicalTrials.gov
• Predictors of therapeutic response and pain after near-infrared photoimmunotherapy in head and neck cancer#338819OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Pain Related to Head and Neck Cancer (HNC); Implementation and Evaluation of Self-care Measure Due to the Same Illness#967387ClinicalTrials.gov
• C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck#844052ClinicalTrials.gov
• The Effect of Active Nutritional Support On Quality Of Life In Patients With Head And Neck Cancer Receiving Radiotherapy#1030396ClinicalTrials.gov
• A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma#886616ClinicalTrials.gov
• Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck Squamous Cell Carcinoma#803144ClinicalTrials.gov
• Administration of ONS Based on Purple Sweet Potato in Head and Neck Cancer Patients With Radiotherapy#892448ClinicalTrials.gov
• A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)#876899ClinicalTrials.gov
• CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)#895495ClinicalTrials.gov
• E7050 in Combination With Cetuximab Versus Cetuximab Alone in the Treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck#1044900ClinicalTrials.gov
• Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer#804129ClinicalTrials.gov
• A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer#872898ClinicalTrials.gov
• Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer#993849ClinicalTrials.gov
• Using a Head and Neck Maskless Immobilization Device For Patients With Intracranial Tumors#878816ClinicalTrials.gov
• Feasibility Study of the Head and Neck Survivorship Tool: Assessment and Recommendations (HN-STAR)#1046526ClinicalTrials.gov
• Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer#892026ClinicalTrials.gov
• [68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas#1032495ClinicalTrials.gov
• Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation#837196ClinicalTrials.gov
• Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy#906924ClinicalTrials.gov
• Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy#911812ClinicalTrials.gov
• PembROlizumab With or Without Microbial EcOsystem ThErapeutic 4 (MET4) in Advanced Head and Neck Squamous Cell Carcinoma#136306ClinicalTrials.gov
• Skin Biophysical Measures for Assessing Head and Neck Cancer-Related External Lymphedema#801448ClinicalTrials.gov
• A Pilot Study of ALTENS in Improving Dysphagia Induced by IMRT for Head and Neck Cancers#807504ClinicalTrials.gov
• Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma#907319ClinicalTrials.gov
• Outpatient Percutaneous Radiologic Gastrostomy in Patients With Head and Neck Tumors#969354ClinicalTrials.gov
• Stereotactic Radiosurgery in Patients With Head and Neck Region Tumours#992366ClinicalTrials.gov
• Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer#846615ClinicalTrials.gov
• Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck Cancer#908465ClinicalTrials.gov
• Imaging With a PET Agent for Detection of Cancers of the Head and Neck#901805ClinicalTrials.gov
• Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer#890880ClinicalTrials.gov
• Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to Therapy#1010033ClinicalTrials.gov